Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs

Slični predmeti

• A herpes simplex virus 2 (HSV-2) glycoprotein D-expressing nonreplicating dominant-negative HSV-2 virus vaccine is superior to a gD2 subunit vaccine against HSV-2 genital infection in guinea pigs.
  od: Pengwei Zhang, i dr.
  Izdano: (2014-01-01)
• An Adenovirus-Based Recombinant Herpes Simplex Virus 2 (HSV-2) Therapeutic Vaccine Is Highly Protective against Acute and Recurrent HSV-2 Disease in a Guinea Pig Model
  od: Mingming Wan, i dr.
  Izdano: (2023-01-01)
• Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection
  od: Kevin Egan, i dr.
  Izdano: (2020-09-01)
• Assessment of Two Novel Live-Attenuated Vaccine Candidates for Herpes Simplex Virus 2 (HSV-2) in Guinea Pigs
  od: Jonathan D. Joyce, i dr.
  Izdano: (2021-03-01)
• Virus-specific immune memory at peripheral sites of herpes simplex virus type 2 (HSV-2) infection in guinea pigs.
  od: Jingya Xia, i dr.
  Izdano: (2014-01-01)